光学基因组图谱市场规模、份额、按产品、方法、最终用途、组件和地区分類的成长分析 - 产业预测，2025 年至 2032 年

全球光学基因组图谱市场预计将在 2023 年达到 1.159 亿美元，从 2024 年的 1.4047 亿美元增长到 2032 年的 6.5404 亿美元，预测期内（2025-2032 年）的复合年增长率为 21.2%。

光学基因组图谱 (OGM) 市场正在经历显着成长，因为越来越多的实验室寻求可靠地识别短读定序无法有效解决的复杂结构变异。不断扩大的仪器部署和试剂租赁选项，以及在提高通量的同时降低样品成本的化学和流动池技术的创新，正在推动这一市场的扩大。供应商正在透过自动化、云端基础的分析和标准化报告来优化工作流程，从而促进肿瘤学、骨髓恶性肿瘤、罕见疾病以及细胞和基因治疗的品管的可重复性。随着应用从研究测试扩展到更广泛的应用，重点正在转向消耗品、软体和服务。主要趋势包括混合 OGM/NGS 报告、支持 AI 的变异调用以及集中式分析网络的建立，巩固了 OGM 作为全球生物製药公司和实验室的重要基因组表征工具的地位。

目录

介绍

• 调查目标
• 调查范围
• 定义

调查方法

• 资讯收集
• 二次资料和一次资料方法
• 市场规模预测
• 市场假设与约束

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分机会分析

市场动态与展望

• 市场概览
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

关键市场考察

• 关键成功因素
• 竞争程度
• 重大投资机会
• 市场生态系统
• 市场吸引力指数（2024年）
• PESTEL分析
• 总体经济指标
• 价值链分析
• 定价分析
• 监管分析
• 技术分析
• 案例研究

光学基因组图谱市场规模（依产品/服务及复合年增长率）(2025-2032)

• 市场概览
• 装置
• 耗材和试剂
• 软体和服务

光学基因组图谱市场规模（依技术及复合年增长率）(2025-2032)

• 市场概览
• 结构突变检测
• 基因组组装
• 微生物菌株的分类
• 罕见变异的鑑定

光学基因组图谱市场规模（依最终用途和复合年增长率） (2025-2032)

• 市场概览
• 生物技术和製药公司
• 医院和临床实验室
• 学术机构
• 合约研究组织（CRO）

光学基因组图谱市场规模（按组件和复合年增长率） (2025-2032)

• 市场概览
• 硬体
• 软体

光学基因组图谱市场规模及复合年增长率（2025-2032）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市场占有率分析（2024年）
• 主要企业简介
  • 公司详情
  • 产品系列分析
  • 按部门分類的公司份额分析
  • 收益同比对比（2022-2024 年）

主要企业简介

• Bionano Genomics
• Pacific Biosciences
• Oxford Nanopore Technologies
• Illumina
• Thermo Fisher Scientific
• Agilent Technologies
• Qiagen
• Roche
• Bio-Rad Laboratories
• Revvity（PerkinElmer）
• Cytiva（Danaher）
• 10x Genomics

结论和建议

Global Optical Genome Mapping Market size was valued at USD 115.9 million in 2023 and is poised to grow from USD 140.47 million in 2024 to USD 654.04 million by 2032, growing at a CAGR of 21.2% during the forecast period (2025-2032).

The market for Optical Genome Mapping (OGM) is witnessing substantial growth as laboratories increasingly seek reliable identification of complex structural variants that short-read sequencing cannot effectively address. Enhanced access is driven by the expansion of instrument placements and reagent rental options, alongside innovations in chemistry and flow cell technology that boost throughput while reducing sample costs. Vendors are optimizing workflows through automation, cloud-based analysis, and standardized reporting, fostering reproducibility across oncology, hematologic malignancies, rare diseases, and cell-and-gene therapy quality control. As adoption broadens from research trials to widespread application, focus shifts towards consumables, software, and services. Key trends include hybrid OGM and NGS reporting, AI-driven variant calling, and the establishment of centralized analysis networks, solidifying OGM's position as a vital genome characterization tool for biopharma and laboratories worldwide.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Optical Genome Mapping market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Optical Genome Mapping Market Segments Analysis

Global Optical Genome Mapping Market is segmented by Product, Technique, End-Use, Component and region. Based on Product, the market is segmented into Instruments, Consumables & Reagents and Software and Services. Based on Technique, the market is segmented into Structural Variant Detection, Genome Assembly, Microbial Strain Typing and Rare Variant Identification. Based on End-Use, the market is segmented into Biotech & Pharma Companies, Hospitals & Clinical Labs, Academic Institutes and Contract Research Organizations (CROs). Based on Component, the market is segmented into Hardware and Software. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Optical Genome Mapping Market

The growth of the global optical genome mapping market is significantly driven by laboratories adopting comprehensive end-to-end processes that seamlessly integrate optical genome mapping with sequencing, allowing them to tackle complex genomic rearrangements effectively. The establishment of standardized pipelines, the use of reference samples, and the development of detailed interpretative guidelines enable consistent and reproducible results across various locations. Additionally, with larger patient cohorts and evolving reporting necessities, the frequency of repeat kit usage rises. The introduction of cloud-based analysis further accelerates turnaround times and enhances staff productivity, particularly for multi-site implementations, thereby fueling market expansion.

Restraints in the Global Optical Genome Mapping Market

The global optical genome mapping market faces several constraints, primarily due to the requirement for specialized expertise in triaging, classifying, and reporting structural variants. Smaller cohorts often encounter a steep learning curve related to analysis and quality control, with audit documentation adding to their workload. Without standardized cloud solutions and comprehensive standard operating procedures, inconsistencies between different sites can arise, which hampers operational efficiency and impedes the transition from research pilots to established service lines. Such challenges pose significant obstacles to the expansion and growth of the market, limiting its overall share in the industry.

Market Trends of the Global Optical Genome Mapping Market

The global Optical Genome Mapping (OGM) market is witnessing a notable trend towards hybrid solutions that combine OGM with sequencing technologies for comprehensive genome characterization. This integration facilitates enhanced detection of large genomic rearrangements alongside precise identification of breakpoints and variants, promoting a more nuanced understanding of genetic anomalies. The adoption of shared reporting pipelines and harmonized reference sets drives efficiency in analysis, reducing review cycles and increasing concordance among multidisciplinary teams in fields like oncology, hematology, and constitutional genetics. Such advancements not only enhance diagnostic accuracy but also foster collaborative decision-making, establishing a strong momentum for market growth.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Analysis
• Technology Analysis
• Case Studies

Global Optical Genome Mapping Market Size by Product & Service & CAGR (2025-2032)

• Market Overview
• Instruments
• Consumables & Reagents
• Software and Services

Global Optical Genome Mapping Market Size by Technique & CAGR (2025-2032)

• Market Overview
• Structural Variant Detection
• Genome Assembly
• Microbial Strain Typing
• Rare Variant Identification

Global Optical Genome Mapping Market Size by End-Use & CAGR (2025-2032)

• Market Overview
• Biotech & Pharma Companies
• Hospitals & Clinical Labs
• Academic Institutes
• Contract Research Organizations (CROs)

Global Optical Genome Mapping Market Size by Component & CAGR (2025-2032)

• Market Overview
• Hardware
• Software

Global Optical Genome Mapping Market Size & CAGR (2025-2032)

• North America (Product & Service, Technique, End-Use, Component)
  • US
  • Canada
• Europe (Product & Service, Technique, End-Use, Component)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product & Service, Technique, End-Use, Component)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product & Service, Technique, End-Use, Component)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product & Service, Technique, End-Use, Component)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Bionano Genomics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pacific Biosciences
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Oxford Nanopore Technologies
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Illumina
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Qiagen
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Revvity (PerkinElmer)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cytiva (Danaher)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• 10x Genomics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations